Add BrightSurf on Google Email

UNC health provider ushers in first FDA-approved medication for eosinophilic esophagitis

Dupilumab, an FDA-approved medication, offers new hope for patients with eosinophilic esophagitis, a rising condition in the US. The treatment reduces eosinophil counts and improves symptoms of dysphagia, leading to better endoscopic healing and histologic severity improvements.

SourceUniversity of North Carolina Health Care·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateDec 21, 2022

First medical guideline recommends new prescription medications for weight loss, ranks the most effective drugs

The American Gastroenterological Association releases new guidelines recommending medications paired with lifestyle changes for adults struggling to lose weight. The guidelines highlight the importance of treating obesity as a biological disease, reducing health complications like diabetes and fatty liver.

SourceAmerican Gastroenterological Association·JournalGastroenterology·DateOct 20, 2022

Historic data released on physician views on race, ethnicity and diversity in gastroenterology

A nationwide survey found that many physicians are complacent with current levels of diversity, with a significant gap in satisfaction with workplace diversity among Black physicians. The study recommends increasing mentorship opportunities and representation of underrepresented groups in leadership positions to improve workforce diver...

SourceAmerican Gastroenterological Association·JournalGastroenterology·TypeSurvey·DateOct 11, 2022

Fecal transplantation: an effective remedy for life-threatening intestinal infections

A new study conducted by researchers from Aarhus University and Aarhus University Hospital shows that fecal transplantation is an effective cure for life-threatening intestinal infections, with a cure rate of over 90%. The treatment was found to be far superior to the standard treatment, which typically consists of antibiotics.

SourceAarhus University·JournalThe Lancet·TypeRandomized controlled/clinical trial·DateSep 26, 2022

Endoscopy COVID-19 testing requirements disproportionately impact medically underserved communities

Medically underserved communities face significant barriers to endoscopy-related COVID-19 testing, potentially worsening health care disparities. Researchers recommend addressing these challenges by mailing test kits or offering rapid testing to mitigate delays in diagnosis and management of gastrointestinal illnesses.

SourceUniversity of Minnesota Medical School·JournalGastroenterology·TypeSurvey·DateSep 22, 2022

“Unlocking” sarcopenic obesity: A review in portal hypertension & cirrhosis provides clarity on key aspects of disease impact and treatment

Researchers from Tianjin Medical University General Hospital review sarcopenic obesity's impact on liver disease, including nonalcoholic fatty liver disease and cirrhosis. The study aims to clarify the pathogenesis of sarcopenic obesity and identify potential therapeutic avenues.

SourceCactus Communications·JournalPortal Hypertension & Cirrhosis·TypeLiterature review·DateJul 6, 2022

AGA issues clinical guidelines outlining drug treatment plans for patients with irritable bowel syndrome (IBS)

The American Gastroenterological Association has released new clinical guidelines outlining a personalized approach to treating irritable bowel syndrome (IBS) patients. The guidelines recommend prioritizing lifestyle modifications and dietary changes, such as increasing fiber or following the low-FODMAP diet, before seeking advanced tr...

SourceAmerican Gastroenterological Association·JournalGastroenterology·DateJun 21, 2022

AGA releases evidence-based principles to guide creation of national colorectal cancer screening approach

The American Gastroenterological Association has released a series of evidence-based position statements guiding the creation of a national colorectal cancer screening approach. The goal is to eliminate barriers and reduce mortality by ensuring equitable access to CRC screening programs for all individuals.

SourceAmerican Gastroenterological Association·JournalGastroenterology·DateJun 14, 2022

Pediatric liver disease increases risk of developing type 2 diabetes

A new study has found that nonalcoholic fatty liver disease (NAFLD) in children significantly increases the risk of developing type 2 diabetes. The study, published in Clinical Gastroenterology and Hepatology, revealed that among 892 children with NAFLD, 6.6% developed type 2 diabetes, with the incidence rate rising by 3% annually.

SourceUniversity of California - San Diego·JournalClinical Gastroenterology and Hepatology·DateJun 13, 2022

More cardiovascular disease found in lean people with non-alcoholic fatty liver disease than in those who are overweight with the same condition

Researchers discovered that lean individuals with non-alcoholic fatty liver disease (NAFLD) are at a higher risk of developing cardiovascular diseases compared to those who are overweight or obese. Despite lower rates of other health conditions, lean patients with NAFLD exhibited increased prevalence of cardiovascular disease.

New research finds computer assisted colonoscopy identify more precancerous polyps compared to traditional colonoscopy

A new study published in Gastroenterology found that using computer-aided detection during colonoscopies can significantly increase the detection of adenoma, or cancerous and precancerous polyps. The research, led by Dr. Aasma Shaukat, showed a 27% increase in the overall rate of detection in average-risk patients. This technology has ...

SourceNYU Langone Health / NYU Grossman School of Medicine·JournalGastroenterology·TypeRandomized controlled/clinical trial·DateMay 24, 2022

Steps should be taken now to protect future supplies of infant and pediatric formula

A new perspective published in The American Journal of Clinical Nutrition recommends strategies to prevent future shortages and regain public trust. Strategies include a thorough, public process to instill confidence in safe production, assessment of supply system factors, and evaluation of business practices.

SourceAmerican Society for Nutrition·JournalAmerican Journal of Clinical Nutrition·TypeCommentary/editorial·DateMay 17, 2022

Microbes help orchestrate how the gut uses its genes

Researchers found microbes influence which genes are used for fat digestion and absorption, leading to changes in epithelial cells. The study also showed microbes promote lipid absorption and impact systemic processes like weight gain.

SourceDuke University·JournalCellular and Molecular Gastroenterology and Hepatology·TypeExperimental study·DateMay 13, 2022

More cardiovascular disease found in lean people with non-alcoholic fatty liver disease than in those who are overweight with the same condition

A new study found that lean individuals with non-alcoholic fatty liver disease (NAFLD) have a higher prevalence of cardiovascular disease compared to those who are overweight or obese. Despite having lower risks for other metabolic and cardiovascular conditions, lean patients with NAFLD were more likely to develop cardiovascular disease.